Skip to content
Screener

Edwards Lifesciences EW Return on equity

Return on equity at other companies

Abbott logo
AbbottABT
10.7%-20.4pp
Artivion logo
ArtivionAORT
3.1%+1.8pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp
ICU Medical logo
ICU MedicalICUI
-0.4%-0.2pp
Boston Scientific logo
Boston ScientificBSX
14.8%+5.2pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
16.8%+3.0pp

Other financials

Income statement

See full
Revenue$1.7B+13.6%
Gross profit$1.3B+13.5%
Operating income$513.2M+24.8%
Net income$241.9M-27.4%
EPS (diluted)$0.42-25.0%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.28B+11.2%
Enterprise value$49.54B+11.0%
P/E51×+39.9×
P/S7.9×-0.2×

Profitability

See full
Gross margin77.8%-1.0pp
Operating margin22.3%-3.6pp
Net margin15.4%-57.5pp
FCF margin17.3%

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Calculated from Edwards Lifesciences’s reported figures.

Based on trailing twelve months.

The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →

Filed
May 6, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001099800-26-000026

FAQ

What is Edwards Lifesciences's return on equity?
Edwards Lifesciences (EW) reported return on equity of 10.7% in Q1 2026.
How has Edwards Lifesciences's return on equity changed year-over-year?
Edwards Lifesciences's return on equity decreased by 77.9% year-over-year, from 48.5% to 10.7%.
What is the long-term trend for Edwards Lifesciences's return on equity?
Over 5 years (2020 to 2025), Edwards Lifesciences's return on equity has grown at a -11.0% compound annual growth rate (CAGR), from 18.9% to 10.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Edwards Lifesciences's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude